Matthew Vogt, MD, PhD, was awarded an R01 from NIAID to generate new monoclonal antibodies in hopes of informing pan-enterovirus vaccines.
Read the full story here.
Matthew Vogt, MD, PhD, was awarded an R01 from NIAID to generate new monoclonal antibodies in hopes of informing pan-enterovirus vaccines.
Read the full story here.